Introduction
Material and methods
Subjects
Genotyping of SNPs
Statistical analyses
Results
Study population
Independent variables | LDH patients | Healthy controls | p value |
---|---|---|---|
(n = 380) | (n = 400) | ||
Age | |||
≤ 50 [N (%)] | 177 (46.6%) | 203 (51.0%) | |
> 50 [N (%)] | 203 (53.4%) | 197 (49.0%) | |
Gender | 0.610 | ||
Female [N (%)] | 152 (40%) | 166 (41.0%) | |
Male [N (%)] | 228 (60%) | 234 (59.0%) | |
Mean age (mean ± SD, years) | 50.43 ± 12.27 | 50.79 ± 8.13 | 0.629 |
Smoking | |||
Yes | 43 (11.3%) | 186 (46.5%) | |
No | 337 (88.7%) | 214 (53.5%) | |
Drinking | |||
Yes | 12 (3.2%) | 168 (42.0%) | |
No | 368 (96.8%) | 232 (58.0%) |
Hardy–Weinberg equilibrium and SNP alleles
SNP ID | Gene | Alleles A/B | Case | Control | MAF | HWE, p † | Allele model | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AA count | AB count | BB count | AA count | AB count | BB count | Case | Control | OR (95% CI) | p ‡ | ||||
rs667282 | CHRNA5 | C/T | 90 | 187 | 102 | 91 | 196 | 113 | 0.484 | 0.473 | 0.764 | 1.05 (0.86–1.28) | 0.645 |
rs16969948 | CHRNA5 | G/A | 1 | 39 | 339 | 2 | 42 | 356 | 0.054 | 0.058 | 0.377 | 0.94 (0.61–1.45) | 0.770 |
rs588765 | CHRNA5 | T/C | 15 | 133 | 232 | 17 | 121 | 262 | 0.214 | 0.194 | 0.523 | 1.14 (0.89–1.45) | 0.310 |
rs6495306 | CHRNA5 | G/A | 15 | 132 | 232 | 17 | 121 | 262 | 0.214 | 0.194 | 0.523 | 1.13 (0.88–1.45) | 0.328 |
rs17486278 | CHRNA5 | C/A | 27 | 133 | 219 | 29 | 163 | 208 | 0.247 | 0.276 | 0.803 | 0.86 (0.68–1.08) | 0.185 |
rs680244 | CHRNA5 | T/C | 27 | 151 | 202 | 26 | 149 | 224 | 0.270 | 0.252 | 0.894 | 1.10 (0.87–1.38) | 0.422 |
rs569207 | CHRNA5 | T/C | 94 | 185 | 100 | 91 | 196 | 113 | 0.492 | 0.473 | 0.764 | 1.08 (0.89–1.32) | 0.439 |
rs692780 | CHRNA5 | C/G | 18 | 131 | 231 | 19 | 124 | 257 | 0.220 | 0.203 | 0.438 | 1.11 (0.87–1.42) | 0.404 |
rs3743077 | CHRNA3 | T/C | 21 | 140 | 219 | 21 | 136 | 243 | 0.239 | 0.223 | 0.772 | 1.10 (0.87–1.39) | 0.426 |
rs1317286 | CHRNA3 | G/A | 5 | 61 | 314 | 6 | 64 | 330 | 0.093 | 0.095 | 0.150 | 0.98 (0.70–1.38) | 0.915 |
rs938682 | CHRNA3 | G/A | 87 | 179 | 114 | 78 | 196 | 125 | 0.464 | 0.441 | 1.000 | 1.10 (0.90–1.34) | 0.354 |
rs12914385 | CHRNA3 | T/C | 25 | 136 | 219 | 26 | 165 | 209 | 0.245 | 0.271 | 0.448 | 0.87 (0.69–1.09) | 0.232 |
rs2869546 | CHRNA3 | C/T | 19 | 139 | 222 | 20 | 135 | 242 | 0.233 | 0.220 | 0.884 | 1.07 (0.85–1.36) | 0.557 |
rs3743075 | CHRNA3 | T/C | 71 | 183 | 117 | 92 | 181 | 123 | 0.438 | 0.461 | 0.107 | 0.91 (0.75–1.12) | 0.369 |
rs8040868 | CHRNA3 | C/T | 36 | 157 | 186 | 40 | 186 | 174 | 0.302 | 0.333 | 0.369 | 0.87 (0.70–1.08) | 0.198 |
Association between CHRNA5/CHRNA3 and the risk of LDH
Group | Variants | OR (95%CI) | p | Group | Variants | OR (95%CI) | p |
---|---|---|---|---|---|---|---|
≤ 50 | Age | 0.91 (0.87–0.96) | < 0.001 | > 50 | Age | 1.07 (1.02–1.11) | 0.004 |
Smoking | 0.17 (0.07–0.43) | < 0.001 | Smoking | 0.11 (0.06–0.24) | < 0.001 | ||
Drinking | 0.05 (0.02–0.15) | < 0.001 | Drinking | 0.07 (0.03–0.18) | < 0.001 | ||
Gender | 0.07 (0.03–0.13) | < 0.001 | Gender | 0.52 (0.29–0.94) | 0.032 | ||
rs8040868-TT | 1 | rs8040868-TT | 1 | ||||
rs8040868-CT | 1.11 (0.44–2.79) | 0.819 | rs8040868-CT | 1.02 (0.43–2.41) | 0.96 | ||
rs8040868-CC | 0.64 (0.25–1.64) | 0.351 | rs8040868-CC | 1.07 (0.45–2.5) | 0.883 | ||
Age | 0.91 (0.87–0.96) | < 0.001 | Age | 1.07 (1.02–1.11) | 0.004 | ||
Smoking | 0.17 (0.07–0.42) | < 0.001 | Smoking | 0.11 (0.06–0.24) | < 0.001 | ||
Drinking | 0.05 (0.02–0.15) | < 0.001 | Drinking | 0.07 (0.03–0.18) | < 0.001 | ||
Gender | 0.07 (0.03–0.13) | < 0.001 | Gender | 0.52 (0.29–0.95) | 0.032 | ||
rs8040868-TT VS. (CT + CC) | 0.63 (0.37–1.07) | 0.084 | rs8040868-TT VS. (CT + CC) | 1.03(0.62–1.71) | 0.909 | ||
Age | 0.91 (0.87–0.96) | < 0.001 | Age | 1.07 (1.02–1.11) | 0.004 | ||
Smoking | 0.17 (0.07–0.42) | < 0.001 | Smoking | 0.11 (0.06–0.24) | < 0.001 | ||
Drinking | 0.05 (0.02–0.16) | < 0.001 | Drinking | 0.07 (0.03–0.18) | < 0.001 | ||
Gender | 0.07 (0.03–0.13) | < 0.001 | Gender | 0.52 (0.29–0.94) | 0.032 | ||
rs8040868-(TT + CT)VS.CC | 1.16(0.48–2.8) | 0.749 | rs8040868-(TT + CT)VS.CC | 0.96 (0.43–2.16) | 0.916 | ||
Male | Age | 0.94 (0.91–0.97) | < 0.001 | Female | Age | 1.08 (1.05–1.11) | < 0.001 |
Smoking | 0.12 (0.06–0.21) | < 0.001 | Smoking | / | 0.999 | ||
Drinking | 0.05 (0.03–0.11) | < 0.001 | Drinking | / | 0.999 | ||
rs8040868-TT | 1 | rs8040868-TT | 1 | 0.769 | |||
rs8040868-CT | 0.46 (0.25–0.84) | 0.012 | rs8040868-CT | 1.12 (0.68–1.85) | 0.649 | ||
rs8040868-CC | 0.75 (0.28–2.03) | 0.572 | rs8040868-CC | 1.32 (0.59–2.98) | 0.502 | ||
Age | 0.94( 0.92–0.97) | < 0.001 | Age | 0.94 (0.92–0.97) | < 0.001 | ||
Smoking | 0.12 (0.06–0.21) | < 0.001 | Smoking | 0.12 (0.06–0.21) | < 0.001 | ||
Drinking | 0.06 (0.03–0.11) | < 0.001 | Drinking | 0.06 (0.03–0.11) | < 0.001 | ||
rs8040868-TT VS. (CT + CC) | 0.5(0.28–0.89) | 0.019 | rs8040868-TT VS. (CT + CC) | 0.50 (0.28–0.89) | 0.019 | ||
Age | 0.94 (0.91–0.97) | < 0.001 | Age | 1.08 (1.05–1.11) | < 0.001 | ||
Smoking | 0.11 (0.06–0.2) | < 0.001 | Smoking | / | 0.999 | ||
Drinking | 0.06 (0.03–0.12) | < 0.001 | Drinking | / | 0.999 | ||
rs8040868-(TT + CT)VS.CC | 1.11 (0.44–2.85) | 0.821 | rs8040868-(TT + CT)VS.CC | 1.25 (0.57–2.72) | 0.573 |
Association of CHRNA5 haplotypes with the risk of steroid-induced ONFH
Analysis | Gene | SNP | Haplotype | OR (95% CI) | p value † |
---|---|---|---|---|---|
Overall | CHRNA5 | rs667282|rs16969948|rs588765|rs6495306|rs17486278|rs680244|rs569207|rs692780 | TACAACCG | 1 | |
CACAACTG | 1.02 (0.83–1.24) | 0.857 | |||
TACACCCG | 0.79 (0.63–1.00) | 0.047 | |||
TGCAATCG | 1.02 (0.60–1.72) | 0.943 | |||
TATGATCC | 0.90 (0.70–1.15) | 0.387 | |||
TGCAATCC | 0.94 (0.39–2.29) | 0.892 | |||
≤ 50 | CHRNA5 | rs667282|rs16969948|rs588765|rs6495306|rs17486278|rs680244|rs569207|rs692780 | TACAACCG | 1 | |
CACAACTG | 1.15 (0.84–1.59) | 0.390 | |||
TGCAATCG | 0.56 (0.22–1.44) | 0.231 | |||
TACACCCG | 1.46 (1.01–2.13) | 0.047 | |||
TATGATCC | 0.84 (0.56–1.25) | 0.383 | |||
TGCAATCC | 0.9 (0.27–3.02) | 0.860 |